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Patient and system factors of mortality
after hip fracture: a scoping review
K. J. Sheehan1*, B. Sobolev1, A. Chudyk2, T. Stephens1 and P. Guy2,3
Abstract
Background: Several patient and health system factors were associated with the risk of death among patients with
hip fracture. However, without knowledge of underlying mechanisms interventions to improve survival post hip
fracture can only be designed on the basis of the found statistical associations.
Methods: We used the framework developed by Arksey and O’Malley and Levac et al. for synthesis of factors and
mechanisms of mortality post low energy hip fracture in adults over the age of 50 years, published in English,
between September 1, 2009 and October 1, 2014 and indexed in MEDLINE. Proposed mechanisms for reported
associations were extracted from the discussion sections.
Results: We synthesized the evidence from 56 articles that reported on 35 patient and 9 system factors of mortality
post hip fracture. For 21 factors we found proposed biological mechanisms for their association with mortality
which included complications, comorbidity, cardiorespiratory function, immune function, bone remodeling and
glycemic control.
Conclusions: The majority of patient and system factors of mortality post hip fracture were reported by only one
or two articles and with no proposed mechanisms for their effects on mortality. Where reported, underlying
mechanisms are often based on a single article and should be confirmed with further study. Therefore, one cannot
be certain whether intervening on such factors may produce expected results.
Keywords: Scoping review, Hip fracture, Mortality, Patient factors, System factors
What is previously known
 Excess mortality persists for years post hip fracture.
 Several patient and system factors have been
associated with the risk of death in patients with hip
fracture.
 However underlying mechanisms of the found
associations are rarely discussed.
What this study adds
 We synthesized the evidence from 56 recent articles
that reported on 35 patient and 9 system factors of
mortality post hip fracture.
 The majority of factors were reported with no
proposed mechanisms for their effects on mortality.
Where reported, underlying mechanisms are often
based on a single article.
 The proposed biological mechanisms include
complications, comorbidity, cardiorespiratory
function, immune function, bone remodeling and
glycemic control.
Background
Hip fracture is a leading cause of injury related mortality
in older adults [1]. Omsland and colleagues reported
mortality rates five times higher in men and three times
higher in women compared to the general population in
the first year post fracture [2]. This excess mortality per-
sists 10 years post fracture [2, 3].
The existing literature identifies patient and system
factors associated with the risk of death among patients
with hip fracture. However, no attempt has been made
to synthesize this literature on the underlying mecha-
nisms for these associations.
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Without knowledge of mechanisms mediating an as-
sociation, interventions to improve survival post hip
fracture can only be designed on the basis of the re-
ported statistical associations. We believe designing
interventions should rely on knowledge about a modi-
fiable factor with negative effect on survival. Where
modifiable factors lie on the causal pathway between
exposure and outcome determines the focus of an
intervention.
Scoping reviews represent an approach to summar-
izing the range of evidence on a subject, to clarify a
complex concept, and to help refine subsequent re-
search questions for a full systematic review [4, 5].
This review contributes to the existing literature by
synthesizing the evidence available on patient and sys-
tem factors of mortality after hip fracture. To go be-
yond traditional reports, we extract and synthesize
additional information on biological and hypothetical
mechanisms for reported associations. More specific-
ally, the aims of this review are 1) to identify patient
and system factors of mortality after hip fracture, and
2) collate the description of proposed mechanisms for
their associations with mortality.
Methods
The key elements of the scoping review framework in-
clude formulating the research question, identifying rele-
vant studies, selecting studies from electronic database,
charting the extracted data and collating, summarizing
and reporting findings. We extend this framework by
collecting information on the underlying mechanisms
for found associations. We have followed to a widely
recognized framework by Arksey and O’Malley [6] and
recommendations of Levac et al. [5] for conducting and
reporting scoping reviews. This scoping review synthe-
sizes published literature and ethical approval was not
required.
The population of interest is frail adults aged 50 years
or older admitted to acute care with non-pathologic low
energy hip fracture. Concepts of interest include both
patient and system factors. The outcome of interest is
mortality following usual care.
Study selection
One reviewer searched MEDLINE using the search
terms “mortality” Medical Subject Headings [MeSH]
AND “hip fracture” [MeSH] and screened studies for eli-
gibility. Studies were first screened according to title and
abstract with those that appeared suitable selected for a
full-text review using standardized inclusion criteria
(Table 1). Studies marked as ‘maybe for inclusion’ were
screened by a second reviewer for eligibility.
We included reports from 2009 or later to minimize
the potential biasing effects of demographic aging [7–9],
surgical advancements [10], and changes in delivery of
hip fracture care [11–13]. Intervention-based studies
were excluded as they do not reflect hip fracture mortal-
ity following usual care. Studies whose main independ-
ent variables were laboratory tests or operation type
were also excluded as they were considered outside of
the current scope of interest. Finally, only studies which
conducted a regression analysis were included as regres-
sion analysis was deemed a proxy for adequate sample
size [14].
Using a formal instrument, one reviewer extracted au-
thors name, publication date, timing of assessment rela-
tive to the hip fracture event, length of follow up,
patient and system factors from each article. The signifi-
cance of statistical associations between the factors and
mortality was derived from the 95 % confidence intervals
reported in the articles. The proposed mechanisms for
mortality were extracted from discussions by one re-
viewer. The accuracy of extraction was assessed by a sec-
ond reviewer.
Collating, summarizing and reporting results
Patient and system factors of mortality studied in the
reviewed articles are summarized in Tables 2, 3 and 4.
Factors with a proposed mechanism of their effects on
mortality are summarized in Tables 5 and 6 with indica-
tion whether the mechanisms is hypothetical.
Table 1 Inclusion criteria for the literature search
Term Include
Study population Men & women ≥50 years of age with non-pathological low energy hip fracture
Study design 0bservational studies
Factors Patient and system factors of mortality
Associations Estimates from regression analysis
Outcome Mortality (in-hospital, 30 day, 12 month, >12 month)
Date Between Sep 1, 2009 and Oct 1, 2014
Language English
Geography Worldwide
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Table 2 Articles studying mortality in relation to injury and complications
Fracture
type
Injury
severity
Additional
trauma
Shock Complications Cardiovascular
complications
Decubitus ulcer Gastrointestinal
bleeding
Pulmonary
complications
Clostridium
difficile
Renal
failure
Pneumonia Delirium
Belmont 2014 [15] √ √
Neuhaus 2013 [17] √ √
Miller 2012 [22] √
Gold 2012 [24] √
Librero 2012 [23] √
Tarazona-Santabalbina 2012 [47] √*
Lee 2011 [62] √
Miyanishi 2010 [63] √
Vaseenon 2010 [65] √*
Juliebo 2010 [66]
Rahme 2010 [55] √ √
Lapcevic 2010 [57] √ √
Juliebo 2010 [66] √*
Berry 2009 [60] √ √
Gulihar 2009 [41] √
Among all 1 2 1 1 1 1 2 1 1 1 2 1 1
*no statistical association found
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Table 3 Articles studying mortality in relation to demographic factors and comorbidity
Age Sex Race Preadmission residence Functional status Any comorbidity Liver disease Diabetes Malignancy Malnutrition Low Body Mass Index*
Belmont 2014 [15] √
Neuhaus 2013 [17] √ √ √
Williams 2013 [36] √ √ √
Hagino 2013 [16] √
Talsnes 2013 [37] √
Uzoigwe 2013 [19] √ √ √ √
Clement 2013 [42] √
Daugaard 2012 [18] √ √ √
Le-Wendling 2012 [20] √ √ √
Librero 2012 [23] √ √ √
Huddleston 2012 [44] √
Adunsky 2012 [43] √ √
Gupta 2012 [45]
Valizadeh 2012 [46] √ √**** √ √****
Tarazona-Santabalbina 2012 [47] √ √ √ √
Pioli 2012 [48] √
Sanz-Reig 2012 [49] √ √
Vidan 2011 [25] √ √ √
Koval 2011 [26] √ √
Frost 2011 [27] √ √ √ √
Kirkland 2011 [38] √
Carretta 2011 [39] √ √ √ √
Gulcelik 2011 [52] √
Talsnes 2011 [53] √ √ √
Baker 2011 [64]
LeBlanc 2011 [70] √
Holvik 2010 [54] √ √
Kesmezacar 2010 [67] √
Rahme 2010 [55] √ √ √ √ √ √
Forte 2010 [56] √ √ √
Lapcevic 2010 [57] √ √ √ √ √
Miyanishi 2010 [63] √
Juliebo 2010 [66] √ √ √
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Table 3 Articles studying mortality in relation to demographic factors and comorbidity (Continued)
Jamal 2010 [59] √
Bjorgul 2010 [69] √ √ √
Pereira 2010 [58] √ √ √ √**** √
Vaseenon 2010 [65] √
Berry 2009 [60] √ √ √
Lefaivre 2009 [33] √ √ √
Vidal 2009 [35] √ √ √
Feng 2009 [68] √
Among all 23 23 2 3 8 23 2 3 2 2 3
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Table 3 Articles studying mortality in relation to demographic factors and comorbidity (Continued)
Obesity Secondary
Hyperparathyroidism**
Cardiac
disease
Cardiac
arrhythmia
Congestive
heart failure***
Coronary artery
disease¥
Myocardial
infarction§
Cerebrovascular
accident¶
Anemia Cognitive
impairment
Dementia
Belmont 2014 [15] √
Neuhaus 2013 [17] √
Williams 2013 [36] √
Hagino 2013 [16]
Talsnes 2013 [37]
Uzoigwe 2013 [19]
Clement 2013 [42]
Daugaard 2012 [18]
Le-Wendling 2012 [20]
Librero 2012 [23]
Huddleston 2012 [44] √ √ √
Adunsky 2012 [43] √
Gupta 2012 [45] √
Valizadeh 2012 [46]
Tarazona-Santabalbina
2012 [47]
√
Pioli 2012 [48]
Sanz-Reig 2012 [49] √ √
Vidan 2011 [25] √
Koval 2011 [26]
Frost 2011 [27] √
Kirkland 2011 [38]
Carretta 2011 [39] √ √
Gulcelik 2011 [52]
Talsnes 2011 [53]
Baker 2011 [64] √
LeBlanc 2011 [70]
Holvik 2010 [54]
Kesmezacar 2010 [67]
Rahme 2010 [55] √ √ √
Forte 2010 [56]
Lapcevic 2010 [57] √ √
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Table 3 Articles studying mortality in relation to demographic factors and comorbidity (Continued)
Miyanishi 2010 [63] √
Juliebo 2010 [66] √ √
Jamal 2010 [59] √
Bjorgul 2010 [69]
Pereira 2010 [58] √
Vaseenon 2010 [65]
Berry 2009 [60] √ √ √
Lefaivre 2009 [33]
Vidal 2009 [35]
Feng 2009 [68]
Among all 1 1 1 5 5 3 2 2 1 1 7
*Body mass index
** Secondary hyperparathyroidism
*** Congestive heart failure
****no statistical association found
¥ Coronary artery disease
§ Myocardial infarction
¶ Cerebrovascular accident
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Results
Search results
The search produced 241 articles for initial title and ab-
stract screening. Figure 1 shows the selection process
which identified 56 articles used in this review. Among
the selected articles, 21 reported on in-hospital mortality
[15–35], 4 reported on 30 day mortality [36–39], 20 re-
ported on 12 months mortality [40–59], and 11 reported
more than 12 month mortality [60–70].
Patient factors of mortality
We identified 35 patient factors of mortality post hip
fracture reported in the reviewed articles, Tables 2 and 3.
The majority of factors were studied by only one or two
studies included in this review. There is a general con-
sensus in the literature that mortality is associated with
age, sex, comorbidity, functional status, dementia,
arrhythmia and congestive heart failure. We noted con-
flicting reports for the association between mortality and
both fracture type [17, 65] and delirium [47, 62, 66].
For 14 factors we found a proposed mechanism of their
effects on mortality, Table 5. Biological mechanisms in-
cluded comorbidity [47, 70], cardiorespiratory function
[68], immune function [38], bone remodeling [52],
glycemic control [52], and calcium homeostasis [32].
Non-biological mechanisms included hospitalization delay
[50], surgical delay [25, 48] and length of stay [36]. Some
proposed included hypothetical mediators, such as re-
duced reserve capacity [22, 37], a patent foramen ovale
[37] and reduced wound healing [52]. Fig. 2 shows two ex-
amples of the mechanisms proposed for patient factors in
the reviewed articles. First, the onset of complications me-
diates the effect of cardiorespiratory function on mortality
[63]. Second, a hypothetical reduction in reserve capacity
mediates the mortality effect of age and extent of comor-
bidity [22, 37].
System factors of mortality
In the reviewed articles, we identified 9 system factors
of mortality post hip fracture including hospitalization
delay, July admission, surgical delay, anaesthetic type,
intensive care admission, hospital volume, surgeon
volume, nursing volume and length of stay, Table 4.
There is no consensus in the literature on system fac-
tors of mortality. The most studied factor was surgi-
cal delay (9 articles). However, the association of
mortality with surgical delays is disputed by reports
of no association [15, 47, 49, 50]. We also noted
Table 4 Articles studying mortality in relation to system factors
Hospital
volume
Surgeon
volume
Nursing
volume
July
admit
General
anesthetic
Intensive care
admit
Short
stay
Hospitalization
delay
Surgical
delay
Belmont 2014 [15] √*
Li 2014 [61] √ √
Uzoigwe 2013 [19] √
Williams 2013 [36] √ √
Neuman 2012 [21] √
Pioli 2012 [48] √
Vidal 2012 [50] √ √*
Tarazona-Santabalbina
2012 [47]
√* √*
Le-Wendling 2012 [20] √
Sanz-Reig 2012 [49] √*
Daugaard 2012 [18] √
Koval 2011 [26] √
Peleg 2011 [30] √
Schilling 2011 [28] √
Carretta 2011 [39] √
Forte 2010 [56] √ √
Kesmezacar 2010 [67] √
Browne 2009 [34] √* √
Anderson 2009 [31] √
Vidal 2009 [35] √
Among all 1 2 1 1 2 1 1 2 9
*no statistical association found
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conflicting reports for the association between mortal-
ity and both July admission and hospital volume. The
other factors were studied by only one or two studies
included in this review.
For 7 factors we found a proposed mechanism of their
effects on mortality, Table 6. Complications were pro-
posed as a biological mechanism for the mortality effect
of nursing staff volume [28] and hospitalization delay
[50, 61]. Non-biological mechanisms included surgical
delay [28], staffing volume [31] and discharge destin-
ation [36]. Some proposed included hypothetical media-
tors, such as, exposure to inflammatory and
hypercoagulable states [71, 72] and inappropriate plan-
ning, technique or management [34].
Table 5 Proposed mechanisms and mediators for the mortality effect of patient factors
Factor Mechanism Mediator
Age Aging reduces the reserve capacity necessary to cope with a double trauma
of hip fracture and surgery [22, 37].
Hypothesis only
The number of chronic conditions increases with age [47, 70]. Extent of comorbidity
Sex Men present with more comorbidity than women [47, 54, 65, 68]. Extent of comorbidity
Men develop delirium [60], lung infection, pneumonia, and septicemia
more
often than women [54, 68].
Complications
Prefracture function Patients with poorer pre-fracture ambulatory status often have reduced
cardiorespiratory function compared to those with better status [68].
Cardiorespiratory function
Patients with a high degree of dependency are more often delayed to
admission than patients with a low degree of dependency [50].
Hospitalization delay
Patients with poor pre-fracture ambulatory status are quickly placed in nursing homes
while patients with better status wait in hospital for rehabilitation beds [36].
Length of stay
Preadmission residence Institutionalized patients develop pneumonia and pressure ulcer more often than patients
from community [54, 60].
Complications
Socioeconomic status Patients with low socioeconomic status are more often delayed to admission than patients
with high socioeconomic status [50].
Hospitalization delay
Clinical stability Patients who are acutely unstable on admission are delayed to surgery more often than
those who are stable [25, 39].
Surgical delay
Extent of comorbidity Multiple comorbidities diminish reserves for stresses of surgery and delays recovery [37, 38]. Hypothesis only
Patients with more comorbidity are delayed to surgery more often than those with
less comorbidity [25, 48].
Surgical delay
Patients with more comorbidity are quickly placed in nursing homes while patients
with less comorbidity wait in hospital for rehabilitation beds [36].
Length of stay
Body composition Patients with low BMI are more likely to develop adverse cardiac event post hip
fracture surgery [66].
Complications
Patients with low BMI are more likely to be frail [66] and have diminished reserves
to cope with the stress of surgery [38].
Hypothesis only
Patients with low BMI often have reduced cardiorespiratory function and a supressed
immune system [38].
Immune response,
Cardiorespiratory function
History of
cerebrovascular accident
Patients with hemiplegia often have more comorbidity and poor pre-fracture
ambulatory status [68].
Extent of comorbidity,
Pre-fracture function
Dementia Patients with dementia often have more comorbidity and poor pre-fracture
ambulatory status [68].
Extent of comorbidity,
Pre-fracture function
Diabetes Diabetes may lead to poor bone remodeling post hip fracture [52]. Bone remodeling [77]
Diabetes may lead to poor wound healing post hip fracture surgery [52]. Hypothesis only
Patients with diabetes may have poor glycemic control leaving the body prone to infections
and complications after surgery [52].
Glycemic control [78]
Complications
Malnutrition Patients with malnutrition often present with more comorbidity and poor pre-fracture
ambulatory status.(16;38)
Extent of comorbidity,
Pre-fracture function
Myocardial infarction Patent foramen ovale allows procoagulant cell conjugates and fragments to pass
directly from the venous to the arterial blood [37].
Hypothesis only
Secondary
hyperparathyroidism
Patients with secondary hyperparathyroidism often have more comorbidity [51]. Extent of comorbidity
Secondary hyperparathyroidism leads to severely altered calcium homeostasis [32]. Calcium homeostasis
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Discussion
The purpose of this review was to synthesize the informa-
tion available on proposed mechanisms for reported associa-
tions between patient and system factors and mortality after
hip fracture. The articles included in this review point to
plausible mediators in the biological mechanisms for mor-
tality post fracture: complications, comorbidity, cardiorespi-
ratory function, immune function, bone remodeling and
glycemic control. For example, exposure to immobilization
and inflammatory states is the proposed mechanism mediat-
ing the mortality effect of hospitalization delay [71, 72]. As
argued elsewhere, prolonged immobilization leads to poten-
tially fatal complications such as pulmonary embolism and
pneumonia while prolonged hypercoagulable inflammation
leads to potentially fatal complications including stroke and
myocardial infarction [73].
A hypothetical reduction in reserve capacity, whereby
a patient cannot withstand the stress of trauma and their
pre-existing comorbidity [38], was proposed as a mech-
anism for the mortality effect of comorbidity [22, 37]. It
seems plausible, because numerous studies associated
mortality with coexisting arrhythmia, congestive heart
failure, coronary artery disease, myocardial infarction,
anemia and cerebrovascular accident. As noted else-
where, patients undergoing hip fracture surgery require
the reserve capacity to withstand the cardiovascular de-
pressant effect of anaesthesia [74]. For those who survive
beyond the short-term, patients with cardiovascular dis-
ease more often present with reduced reserve exercise
capacity [75] compromising their rehabilitation potential
and placing them at greater risk of dependency, compli-
cations and death [76].
Table 6 Proposed mechanisms and mediators for the effect of system factors on mortality
Factor Mechanism Mediator
Hospital volume Patients admitted to low volume hospitals are often delayed to surgery when compared to
patients admitted to high volume hospitals [56].
Surgical delay
Nursing staff volume Higher nurse staffing may prevent or allow early detection of complications [28]. Complications
Higher nurse staffing improves operating room availability and shorten time to surgery [28]. Surgical delay
Surgeon volume Low volume surgeons may not select appropriate procedure and preoperative planning,
intraoperative technique and postoperative management [34].
Hypothesis only
Surgical delay Patients who are delayed to surgery are exposed to inflammatory and hypercoagulable
states for longer than those who are not delayed [71, 72].
Hypothesis only
Hospitalization delay Patients may receive suboptimal care prior to admission and may develop pressure ulcers,
thromboembolism, uncontrolled pain or delirium [50, 61].
Complications
Length of stay Institutionalized patients have shorter hospital stay than patients from community [36]. Discharge destination
Admission month Patients admitted in July may be exposed to lower staffing levels in holiday period [31]. Staffing volume
Fig. 1 Flow chart of the literature retrieval, review, exclusion and selection with sorting by follow up time. n = number. * = Studies excluded with patient
populations less than 50 years old, pathological or high impact hip fractures, or whose main independent variables were laboratory tests or operation type
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This is the first scoping review to synthesize the pro-
posed biological and hypothetical mechanisms for pa-
tient and system factors of mortality following hip
fracture. Such synthesis represents a first step towards
transparency about underlying assumptions when
informing policy on potential interventions to improve
survival in this vulnerable population.
This review is not without limitations. In contrast to a
systematic review, where literature is critically appraised
on the methodology, we assess the reviewed articles only
according to the presence of proposed mechanisms for
the reported associations. This is a common approach in
scoping reviews where the purpose is to collate the evi-
dence on a topic of interest. [5] The search strategy was
restricted to one database over a 5 year period preceding
the review development to minimize the potential bias-
ing effects of surgical advancements [10], and changes in
delivery of hip fracture care [11–13]. We excluded arti-
cles reporting outcomes of interventions as they do not
reflect hip fracture mortality resulting from usual care.
These restrictions may result in lacking some articles
both on factors of mortality and proposed mechanisms.
Conclusions
We synthesized proposed mechanisms for reported asso-
ciations between patient and system factors and mortal-
ity after hip fracture. We identified complications,
comorbidity, cardiorespiratory function, immune func-
tion and bone remodeling and glycemic control as plaus-
ible mediators in the biological mechanisms for
mortality post fracture. However, we found that the ma-
jority of patient and system factors of mortality post hip
fracture were reported by only one or two articles and
with no proposed mechanisms for their effects on
mortality. Where reported, underlying mechanisms are
often based on a single article and should be confirmed
with further study. Therefore, one cannot be certain
whether intervening on such factors may produce ex-
pected results.
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